Amneal Pharmaceuticals, Inc. (AMRX) stock analysis

AMRX · Amneal Pharmaceuticals, Inc.

Latest recorded price: USD 21.23

Model-estimated fair value: USD 14.08. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

At $21.23, AMRX trades 50.8% above the model's base-case value of $14.08. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $9.21 in the conservative case and $19.68 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 10.9%, free cash flow margin 8.9%, ROIC 11.5%. The model does not flag any risk signals for this company.

Similar companies in Healthcare